EB-2 NIWBiotech and pharmaIndividualDecided 2018Sustained
Outcome: Sustained
JUL132018_01B5203
Merit and national importanceMetWell positionedMetBalance favors a waiverMet
Our summary
A biostatistics researcher with a Ph.D. sought an EB-2 national interest waiver. He proposed research improving clinical trial design and quality-of-life studies. The AAO sustained his appeal, finding all three Dhanasar prongs satisfied: substantial merit and national importance, well-positioned qualifications, and net benefit to the nation.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
What the AAO accepted
- Merit and national importance · Proposed research in clinical trials and quality-of-life studies has substantial merit and national importance
- Well positioned · Past experience uncovering statistical flaws and advancing methodologies demonstrates capability
- Balance favors a waiver · Track record and significance of proposed work would benefit United States despite available qualified workers
What was missing
Every criterion in the table was found met.
Criteria
| Criterion | Reading | Why |
|---|---|---|
 Merit and national importance | Met | Proposed research in clinical trials and quality-of-life studies has substantial merit and national importance |
 Well positioned | Met | Past experience uncovering statistical flaws and advancing methodologies demonstrates capability |
 Balance favors a waiver | Met | Track record and significance of proposed work would benefit United States despite available qualified workers |
A published decision describes one case. It is not legal advice and not a prediction for yours.